Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas.

EBioMedicine · 2019 · PMC6413473 · PMID 30711517

Europe PMC DOI

hedged sentence

0.0895

closest p · 1.8× alpha

0.0895

boldest claim

The sentences

did not reach statistical significancep = 0·0895so close (0.05 < p ≤ 0.1)

1), but this difference did not reach statistical significance (p = 0·0895) [Chi-square test]. 4 Discussion This study examined the effects of the chimeric anti-mouse PDGFRα antibody 1E10Fc alone or in combination with fractionated RT in a primary mouse model of STS.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.